Esophageal cancer
Conditions
Interventions
Group 1 (Thoracotomy for radical esophagectomy):Traditional surgery
Group 2 (Thoracoscopy and laparoscopic surgery for radical esophagectomy):Minimally invasive surgery
Group 3 (flurbiprofen ester 1 mg/kg preemptive analgesia, thoracoscopy and laparoscopic surgery for radical esophagectomy).:flurbiprofen ester preemptive analgesia
Sponsors
Cancer Hospital Affiliated to Zhengzhou University & Henan Cancer Hospital
Eligibility
Sex/Gender
All
Age
46 Years to 70 Years
Inclusion criteria
Inclusion criteria: (ASA I-II) patients, without gender limitation, aged 46 to 70 years old, weight 50 ~ 80 kg, no drug allergy history, abnormal bleeding history, no coagulation dysfunction, no history of ulcer disease; liver and kidney function was normal, did not use non-steroidal anti-inflammatory drugs and quinolones antibiotics within 3 days before surgery.
Exclusion criteria
Exclusion criteria: Geting blood failure, blood coagulation, blood loss, temporary changes in surgical procedures (laparoscopic to open thoracotomy, radical surgery to thoracotomy) and surgical delay (surgery is too complex, too long)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CD3+;CD19+;NK;CD4+;CD8+; | — |
Countries
China
Contacts
Public ContactLu Xihua
Cancer Hospital Affiliated to Zhengzhou University & Henan Cancer Hospital
Outcome results
None listed